Hajime Oishi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hajime Oishi has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Akira Kuwahara
Department of Obstetrics and Gynecology The University of Tokushima Graduate School Institute of Health Biosciences 3‐18‐15 Kuramoto‐Cho Tokushima 770‐8503 Japan
1 shared publication - Akira Tsujimura
Department of Urology Juntendo University Urayasu Hospital Urayasu Japan
1 shared publication - Atsushi Fukui
Department of Obstetrics and Gynecology, School of Medicine Hyogo Medical University Nishinomiya Hyogo Japan
1 shared publication - Fuminori Kimura
Department of Obstetrics and Gynecology Nara Medical University Kashihara Japan
1 shared publication Hajime Yoshihara
Japan Community Health Care Organization Sagamino Hospital Center of Perinatal Medicine Kanagawa Japan
1 shared publication- Haruhiko Kanasaki
Department of Obstetrics and Gynecology, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan
1 shared publication
Latest Publications
- Open Access
- 24 August 2022
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 21 (1) , e12483
Guidelines for Reproductive Medicine in Japan
- 24 August 2022
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 21 (1) , e12483
Open AccessGuidelines for Reproductive Medicine in Japan
- 9 December 2020
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 47 (2) , 734-744
Effects of maternal and fetal choline concentrations on the fetal growth and placental DNA methylation of 12 target genes related to fetal growth, adipogenesis, and energy metabolism
Aim We performed a birth cohort study involving 124 mother–infant pairs to investigate whether placental DNA methylation is associated with maternal choline status and fetal development. Methods Plasma choline concentration was assayed longitudinally in the 1st and 3rd trimesters and at term‐pregnancy in mothers and cord blood. Placental DNA methylation was measured for 12 target candidate genes that are related to fetal growth, adipogenesis, lipid and energy metabolism, or long interspersed nuclear elements. Results Higher maternal plasma and cord blood choline levels at term tended to associate with lower birthweight (r = −0.246, P < 0.013; r = −0.290, P < 0.002) and body mass index (BMI) at birth (r = 0.344, P < 1E−3; r = −0.360, P < 1E−3). The correlation between maternal plasma choline level and cord blood choline level was relatively modest (r = 0.049, P = 0.639). There was an inverse correlation between placental DNA methylation at the retinoid X receptor alpha (RXRA) gene and maternal plasma choline level (r = −0.188 to r = −0.452, P = 0.043 to P < 1E−3 at three points). RXRA methylation level was positively associated with birthweight and BMI at birth (r = 0.306, P = 0.001; r = 0.390, P < 1E−3). Further, RXRA methylation was inversely correlated with RXRA gene expression level (r = 0.333, P < 1E−3). Conclusion Our results suggest that the association between maternal choline status and placental RXRA methylation represents a potential fetal programing mechanism contributing to fetal growth.
- 9 December 2020
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 47 (2) , 734-744
Effects of maternal and fetal choline concentrations on the fetal growth and placental DNA methylation of 12 target genes related to fetal growth, adipogenesis, and energy metabolism
Aim We performed a birth cohort study involving 124 mother–infant pairs to investigate whether placental DNA methylation is associated with maternal choline status and fetal development. Methods Plasma choline concentration was assayed longitudinally in the 1st and 3rd trimesters and at term‐pregnancy in mothers and cord blood. Placental DNA methylation was measured for 12 target candidate genes that are related to fetal growth, adipogenesis, lipid and energy metabolism, or long interspersed nuclear elements. Results Higher maternal plasma and cord blood choline levels at term tended to associate with lower birthweight (r = −0.246, P < 0.013; r = −0.290, P < 0.002) and body mass index (BMI) at birth (r = 0.344, P < 1E−3; r = −0.360, P < 1E−3). The correlation between maternal plasma choline level and cord blood choline level was relatively modest (r = 0.049, P = 0.639). There was an inverse correlation between placental DNA methylation at the retinoid X receptor alpha (RXRA) gene and maternal plasma choline level (r = −0.188 to r = −0.452, P = 0.043 to P < 1E−3 at three points). RXRA methylation level was positively associated with birthweight and BMI at birth (r = 0.306, P = 0.001; r = 0.390, P < 1E−3). Further, RXRA methylation was inversely correlated with RXRA gene expression level (r = 0.333, P < 1E−3). Conclusion Our results suggest that the association between maternal choline status and placental RXRA methylation represents a potential fetal programing mechanism contributing to fetal growth.